OptimizeRx CorporationOPRXNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+21.5%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+21.5%/yr
vs +96.3%/yr prior
Acceleration
-74.8pp
Decelerating
Percentile
P100
Near historical high
vs 3Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$18.66M+290.6%
2024$4.78M+158.9%
2023$-8.11M-177.9%
2022$10.41M+4236.6%
2021$240040.00+103.7%
2020$-6.44M-98.1%
2019$-3.25M-563.1%
2018$701542.00+146.1%
2017$-1.52M-86.6%
2016$-815503.00-